Genovac
Fargo, ND, United States genovac.com From their website, Nov 2026
Work here? Claim this listing
About
Genovac is a contract research and manufacturing organization focused on antibody discovery and production against challenging targets, as well as recombinant protein and plasmid DNA production. It serves biotech and pharma clients from sites in Fargo, North Dakota, and Freiburg, Germany.
Services
Immunization strategies
Uses genetic immunization, protein immunization, peptide immunization, and other options such as cells, AAV, VLP, and nanodisc to generate antibodies against protein targets.
Host species options
Runs antibody discovery campaigns in multiple wild type and human-Ig transgenic species and strains, including multi-species approaches.
Single B cell platforms
Performs automated single B cell antibody discovery and screening using Beacon, Genovac Nano, and 10X Genomics ChromiumX + NGS platforms.
Advanced hybridoma
Generates hybridomas using semi-solid and well-based fusion workflows for antibody discovery and clone selection.
Antibody humanization
Uses AI-based humanization workflows to generate humanized antibody variants and support one-to-many candidate optimization.
Antibody sequencing
Provides in-house hybridoma and single B cell antibody sequencing using Sanger and NGS methods.
Antibody production
Produces antibodies from small-scale parallel production through scale-up production and process development.
Protein production
Antibody characterization
Characterizes antibodies with binding kinetics and epitope binning using Carterra LSA HT-SPR and Gator Plus BLI.
11 more services
- Antibody functional assays
- Recombinant protein production
- Plasmid DNA production
- Catalog antibodies
- Antibody Discovery - Hybridoma
- Antibody Discovery - Single B Cell
- Antibody Characterization - Affinity Measurement & Binding Kinetics
- Antibody Characterization - Functional Assays
- Plasmid Production
- Protein & Plasmid Production
- Genetic Immunization
- Turnaround
- Typical turnaround time of 2-3 weeks
- Typical turnaround time of 3-4 weeks
- Reduces the total development timeline by six to ten weeks
- Reducing the development schedule by four to eight weeks
- What to send
- DNA
- An electronic sequence
- An accession number
- Purified recombinant proteins
- Peptide conjugates
- Flash-frozen hybridoma cells
5 more
- RNA-stabilized hybridoma cells
- Crude supernatants
- Purified antibodies
- Electronic sequence
- Accession number
- Minimums and prices
- Price 100 µg
Capabilities
- Assays and studies
- Antibodies
- Hybridoma
- NGS
- Binding kinetics
- Epitope binning
- Flow cytometry
17 more
- ELISA
- C-ELISA
- Immunofluorescence
- Western blot
- Immunohistology
- Neutralization
- Cytotoxicity
- Cross-reactivity
- Blocking
- Internalization
- Cell-based assays
- Bead-based assays
- Affinity measurement
- Functional assays
- Single B cell screening
- Antibody sequencing
- Humanization
- Scale and capacity
- Up to 96 antibodies per batch
- Culture volumes of 5 mL
- Culture volumes from 65-900 mL
- Culture volumes of 1.4-20 L
- Up to 160,000 individual B cells
- Up to 1 million single plasma cells or plasmablasts per project
7 more
- Up to 384 antibodies for binding kinetics
- Up to a 192 x 192 antibody array for epitope binning
- Up to 24 antibodies for binding kinetics
- Up to a 12 x 12 antibody array for epitope binning
- Microgram to gram scale
- Over 3,600 antibody discovery projects
- 25 years of experience
- Therapeutic areas
- Biopharmaceutical
- Therapeutic
- Diagnostic
- Drugs
Instruments and platforms
- Bruker Beacon
- Genovac Nano
- 10X Genomics ChromiumX
- Tecan Fluent
- Carterra LSA HT-SPR
- Gator Bio Gator Plus BLI
6 more
- Sartorius Incucyte S3
- Molecular Devices SpectraMax i3x
- Thermo Scientific Attune Flow Cytometers
- Sartorius iQue
- Berkeley Lights Beacon
- 10X Genomics ChromiumX + NGS
Modalities and species
- Modalities
- Antibody
- Peptide
- Viral vector
- Recombinant protein
- Plasmid DNA
- Species and models
- Mouse
- Rat
- Rabbit
- Llama
- Human PBMC
- HEK
8 more
- CHO
- E. coli
- Insect
- Mammalian
- HEK-293
- Wild type species
- Human-Ig transgenic species
- Strains
Industries served
- Biotech
- Pharma
- Biopharmaceutical
- Agricultural
- Diagnostic
Company
- Type
- CRDMO
- Founded
- 1999
- Quality
- Research grade (plasmid DNA) · enhanced research grade (plasmid DNA)
Locations
- Address
- 1810 NDSU Research Circle N Suite B Fargo, ND 58102
- Sites
- Freiburg, Germany
- Serves
- USA & Canada, Europe
Contacts
- Phone
- +1 (701) 551-2770